• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MZe786在高可溶性血管内皮生长因子受体1(sFlt-1)和低血红素加氧酶-1(HO-1)环境中挽救心脏线粒体活性。

MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment.

作者信息

Sanchez-Aranguren Lissette Carolina, Rezai Homira, Ahmad Shakil, Alzahrani Faisal A, Sparatore Anna, Wang Keqing, Ahmed Asif

机构信息

Aston Medical Research Institute, Aston Medical School, Birmingham B4 7ET, UK.

Mirzyme Therapeutics, Innovation Birmingham Campus, Faraday Wharf, Holt Street, Birmingham B7 4BB, UK.

出版信息

Antioxidants (Basel). 2020 Jul 9;9(7):598. doi: 10.3390/antiox9070598.

DOI:10.3390/antiox9070598
PMID:32660064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7402164/
Abstract

Hypertensive disorder in pregnancy is a major cause of maternal and perinatal mortality worldwide. Women who have had preeclampsia are at three to four times higher risk in later life of developing high blood pressure and heart disease. Soluble Flt-1 (sFlt-1) is elevated in preeclampsia and may remain high postpartum in women with a history of preeclampsia. Heme oxygenase-1 (Hmox1/HO-1) exerts protective effects against oxidative stimuli and is compromised in the placenta of pregnant women with preeclampsia. We hypothesized that sFlt-1 inhibits cardiac mitochondrial activity in HO-1 deficient mice. HO-1 haplo-insufficient mice (Hmox1) were injected with adenovirus encoding sFlt-1 (Ad-sFlt-1) or control virus (Ad-CMV). Subsequently, they were treated daily with either placebo or MZe786 for six days, when the heart tissue was harvested to assess cardiac mitochondrial activity. Here, we show that the loss of HO-1 disturbed cardiac mitochondrial respiration and reduced mitochondrial biogenesis. The overexpression of sFlt-1 resulted in the inhibition of the cardiac mitochondrial activity in Hmox1 mice. The present study demonstrates that the hydrogen sulfide (HS) releasing molecule, MZe786, rescues mitochondrial activity by stimulating cardiac mitochondrial biogenesis and antioxidant defense in Hmox1 mice and in Hmox1 mice exposed to a high sFlt-1 environment.

摘要

妊娠期高血压疾病是全球孕产妇和围产期死亡的主要原因。患有先兆子痫的女性在晚年患高血压和心脏病的风险要高出三到四倍。可溶性Flt-1(sFlt-1)在先兆子痫中升高,并且在有先兆子痫病史的女性产后可能仍然居高不下。血红素加氧酶-1(Hmox1/HO-1)对氧化刺激具有保护作用,并且在患有先兆子痫的孕妇胎盘中受损。我们假设sFlt-1会抑制HO-1缺陷小鼠的心脏线粒体活性。给HO-1单倍体不足小鼠(Hmox1)注射编码sFlt-1的腺病毒(Ad-sFlt-1)或对照病毒(Ad-CMV)。随后,它们每天接受安慰剂或MZe786治疗六天,之后采集心脏组织以评估心脏线粒体活性。在此,我们表明HO-1的缺失扰乱了心脏线粒体呼吸并减少了线粒体生物合成。sFlt-1的过表达导致Hmox1小鼠心脏线粒体活性受到抑制。本研究表明,释放硫化氢(HS)的分子MZe786通过刺激Hmox1小鼠以及暴露于高sFlt-1环境的Hmox1小鼠的心脏线粒体生物合成和抗氧化防御来挽救线粒体活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/1ee8f75c6879/antioxidants-09-00598-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/0a36e1e50a3f/antioxidants-09-00598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/e7da4cd1851b/antioxidants-09-00598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/7e0500f58313/antioxidants-09-00598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/1ee8f75c6879/antioxidants-09-00598-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/0a36e1e50a3f/antioxidants-09-00598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/e7da4cd1851b/antioxidants-09-00598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/7e0500f58313/antioxidants-09-00598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfc/7402164/1ee8f75c6879/antioxidants-09-00598-g004.jpg

相似文献

1
MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment.MZe786在高可溶性血管内皮生长因子受体1(sFlt-1)和低血红素加氧酶-1(HO-1)环境中挽救心脏线粒体活性。
Antioxidants (Basel). 2020 Jul 9;9(7):598. doi: 10.3390/antiox9070598.
2
MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment.MZe786,一种释放硫化氢的阿司匹林,可预防高可溶性 flt-1 环境下血红素加氧酶-1 单倍体缺乏型妊娠子痫前期。
Redox Biol. 2021 Jan;38:101768. doi: 10.1016/j.redox.2020.101768. Epub 2020 Oct 24.
3
Molecular mechanisms and therapeutic implications of the carbon monoxide/hmox1 and the hydrogen sulfide/CSE pathways in the prevention of pre-eclampsia and fetal growth restriction.一氧化碳/血红素加氧酶 1 和硫化氢/CSE 通路在预防子痫前期和胎儿生长受限中的分子机制及治疗意义。
Pregnancy Hypertens. 2014 Jul;4(3):243-4. doi: 10.1016/j.preghy.2014.04.013. Epub 2014 Jul 9.
4
Hydrogen sulfide releasing molecule MZe786 inhibits soluble Flt-1 and prevents preeclampsia in a refined RUPP mouse model.硫化氢释放分子MZe786在改良的RUPP小鼠模型中抑制可溶性Flt-1并预防子痫前期。
Redox Biol. 2021 Jan;38:101814. doi: 10.1016/j.redox.2020.101814. Epub 2020 Nov 28.
5
Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.血红素加氧酶-1对可溶性Flt-1和可溶性内皮糖蛋白释放的负调控
Circulation. 2007 Apr 3;115(13):1789-97. doi: 10.1161/CIRCULATIONAHA.106.660134. Epub 2007 Mar 26.
6
Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia.他汀类药物的治疗潜力及子痫前期中血红素加氧酶-1的诱导作用
J Reprod Immunol. 2014 Mar;101-102(100):153-160. doi: 10.1016/j.jri.2013.12.120. Epub 2014 Jan 16.
7
Circulating HO-1 levels are not associated with plasma sFLT-1 and GT HMOX1 polymorphism in preeclampsia.子痫前期患者循环中血红素加氧酶-1水平与血浆可溶性血管内皮生长因子受体-1及GT血红素加氧酶-1基因多态性无关。
Hypertens Pregnancy. 2019 May;38(2):73-77. doi: 10.1080/10641955.2019.1582664. Epub 2019 Mar 5.
8
Evidence-Based Revised View of the Pathophysiology of Preeclampsia.基于证据的子痫前期病理生理学修正观点。
Adv Exp Med Biol. 2017;956:355-374. doi: 10.1007/5584_2016_168.
9
Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy.早发型、晚发型子痫前期及正常妊娠中血清血红素加氧酶1(HO-1)、可溶性FMS样酪氨酸激酶(sFlt-1)水平及新生儿结局
Hypertens Pregnancy. 2018 Nov;37(4):175-181. doi: 10.1080/10641955.2018.1494187. Epub 2018 Oct 2.
10
Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.血红素加氧酶-1在子痫前期胎盘组织中未减少,且对胎盘可溶性fms样酪氨酸激酶-1或可溶性内皮糖蛋白的分泌无负向调节作用。
Hypertension. 2015 Nov;66(5):1073-81. doi: 10.1161/HYPERTENSIONAHA.115.05847. Epub 2015 Aug 31.

引用本文的文献

1
TNF-α-Mediated Endothelial Cell Apoptosis Is Rescued by Hydrogen Sulfide.硫化氢可挽救肿瘤坏死因子-α介导的内皮细胞凋亡。
Antioxidants (Basel). 2023 Mar 16;12(3):734. doi: 10.3390/antiox12030734.
2
Advances of HS in Regulating Neurodegenerative Diseases by Preserving Mitochondria Function.硫化氢通过维持线粒体功能在调控神经退行性疾病方面的进展
Antioxidants (Basel). 2023 Mar 6;12(3):652. doi: 10.3390/antiox12030652.
3
Sodium Thiosulphate-Loaded Liposomes Control Hydrogen Sulphide Release and Retain Its Biological Properties in Hypoxia-like Environment.

本文引用的文献

1
Redox Regulation Glutaredoxin-1 and Protein -Glutathionylation.氧化还原调控 谷氧还蛋白 1 与蛋白 - 谷胱甘肽化
Antioxid Redox Signal. 2020 Apr 1;32(10):677-700. doi: 10.1089/ars.2019.7963. Epub 2020 Jan 23.
2
Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy.妊娠高血压女性的长期心血管风险。
J Am Coll Cardiol. 2019 Dec 3;74(22):2743-2754. doi: 10.1016/j.jacc.2019.09.052. Epub 2019 Nov 11.
3
Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study.
载有硫代硫酸钠的脂质体在类缺氧环境中控制硫化氢释放并保留其生物学特性。
Antioxidants (Basel). 2022 Oct 24;11(11):2092. doi: 10.3390/antiox11112092.
4
Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?线粒体氧化应激是子痫前期可行的治疗靶点吗?
Antioxidants (Basel). 2022 Jan 22;11(2):210. doi: 10.3390/antiox11020210.
5
HS Donors and Their Use in Medicinal Chemistry.HS 供体及其在药物化学中的应用。
Biomolecules. 2021 Dec 18;11(12):1899. doi: 10.3390/biom11121899.
6
The impact of COVID-19 on pregnancy and therapeutic drug development.COVID-19 对妊娠和治疗性药物开发的影响。
Br J Pharmacol. 2022 May;179(10):2108-2120. doi: 10.1111/bph.15582. Epub 2021 Jul 6.
子痫前期与心血管疾病在一个大型英国妊娠队列的电子健康记录中的关联:CALIBER 研究。
Circulation. 2019 Sep 24;140(13):1050-1060. doi: 10.1161/CIRCULATIONAHA.118.038080. Epub 2019 Sep 23.
4
Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.母体血清血管生成因子 sFlt-1/PlGF 比值与子痫前期:中国女性鉴别诊断和预后评估的有用标志物。
Dis Markers. 2019 Jul 16;2019:6270187. doi: 10.1155/2019/6270187. eCollection 2019.
5
Mitochondria and cardiovascular diseases-from pathophysiology to treatment.线粒体与心血管疾病——从病理生理学到治疗
Ann Transl Med. 2018 Jun;6(12):256. doi: 10.21037/atm.2018.06.21.
6
Hydrogen Sulfide Biochemistry and Interplay with Other Gaseous Mediators in Mammalian Physiology.硫化氢的生物化学及其与哺乳动物生理学中其他气态介质的相互作用。
Oxid Med Cell Longev. 2018 Jun 27;2018:6290931. doi: 10.1155/2018/6290931. eCollection 2018.
7
Measurement of respiratory function in isolated cardiac mitochondria using Seahorse XFe24 Analyzer: applications for aging research.使用 Seahorse XFe24 分析仪测量分离的心肌线粒体中的呼吸功能:在衰老研究中的应用。
Geroscience. 2018 Jun;40(3):347-356. doi: 10.1007/s11357-018-0021-3. Epub 2018 Jun 2.
8
Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia.可溶性Fms样酪氨酸激酶-1改变子痫前期的细胞代谢和线粒体生物能量学。
Front Physiol. 2018 Mar 6;9:83. doi: 10.3389/fphys.2018.00083. eCollection 2018.
9
Hydrogen sulfide mediates athero-protection against oxidative stress via S-sulfhydration.硫化氢通过 S-巯基化介导抗动脉粥样硬化氧化应激保护。
PLoS One. 2018 Mar 8;13(3):e0194176. doi: 10.1371/journal.pone.0194176. eCollection 2018.
10
New data about preeclampsia: some possibilities of prevention.关于先兆子痫的新数据:一些预防的可能性。
Gynecol Endocrinol. 2018 Aug;34(8):636-637. doi: 10.1080/09513590.2018.1441401. Epub 2018 Mar 6.